 | • レポートコード：QAF27539 • 出版社/出版日：QYResearch / 2021年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のアシネトバクター感染症治療市場について種類別（スルバクタム、カルバペネム系抗生物質、アミノグリコシド系抗生物質、ポリミキシン系抗生物質、テトラサイクリン系抗生物質、その他）、用途別（ETX2514、ナクバクタムRG6080、アレニシン、VXD-001、小分子抗生物質、AR-401 mAB、LCB01-0371（PO）、GN-4474、抗菌抗体）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・アシネトバクター感染症治療市場の概要 ・世界の主要地域別アシネトバクター感染症治療市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のアシネトバクター感染症治療市場規模2016-2021：種類別（スルバクタム、カルバペネム系抗生物質、アミノグリコシド系抗生物質、ポリミキシン系抗生物質、テトラサイクリン系抗生物質、その他） ・世界のアシネトバクター感染症治療市場予測2012-2027：種類別（スルバクタム、カルバペネム系抗生物質、アミノグリコシド系抗生物質、ポリミキシン系抗生物質、テトラサイクリン系抗生物質、その他） ・世界のアシネトバクター感染症治療市場規模2016-2021：用途別（ETX2514、ナクバクタムRG6080、アレニシン、VXD-001、小分子抗生物質、AR-401 mAB、LCB01-0371（PO）、GN-4474、抗菌抗体） ・世界のアシネトバクター感染症治療市場予測2012-2027：用途別（ETX2514、ナクバクタムRG6080、アレニシン、VXD-001、小分子抗生物質、AR-401 mAB、LCB01-0371（PO）、GN-4474、抗菌抗体） ・アシネトバクター感染症治療のアメリカ市場規模と予測2016-2021 ・アシネトバクター感染症治療のヨーロッパ市場規模と予測2016-2021 ・アシネトバクター感染症治療の中国市場規模と予測2016-2021 ・アシネトバクター感染症治療の日本市場規模と予測2016-2021 ・アシネトバクター感染症治療の東南アジア市場規模と予測2016-2021 ・アシネトバクター感染症治療のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Entasis Therapeutics、Roche、Adenium Biotech、Vaxdyn、Hsiri Therapeutics、Aridis Pharmaceuticals、LegoChem Biosciences、Atterx Biotherapeutics、Achaogen、Peptilogics、Sealife PHARMA、Shionogi、Techulon、Tetraphase Pharmaceuticals） ・アシネトバクター感染症治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アシネトバクター感染症治療の市場動向・機会・課題 ・調査の結論 |
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
In the last several years, global market of Acinetobacter Infections Treatment developed rapidly, with an average growth rate of 2.96%. In 2016, United States Market Size of Acinetobacter Infections Treatment is nearly 22 M USD. For developing product, there are 1 in Phase III, 1 in Phase Ⅱ, 4 in Phase 1 and 8 in Preclinical. The total investment for Acinetobacter Infections Treatmen Drugs developing is around 90 M USD.
Market Analysis and Insights: Global Acinetobacter Infections Treatment Market
The global Acinetobacter Infections Treatment market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Acinetobacter Infections Treatment Scope and Market Size
The global Acinetobacter Infections Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acinetobacter Infections Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Sulbactam
Carbapenems
Aminoglycosides
Polymyxins
Tetracyclines
Others
Segment by Application
ETX2514
Nacubactam RG6080
Arenicin
VXD-001
Small Molecule Antibiotic
AR-401 mAB
LCB01-0371 (PO)
GN-4474
Antibacterial Antibody
The Acinetobacter Infections Treatment market is analysed and market size information is provided by regions (countries). Segment by Application, the Acinetobacter Infections Treatment market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals
1 Acinetobacter Infections Treatment Market Overview
1.1 Acinetobacter Infections Treatment Product Scope
1.2 Acinetobacter Infections Treatment Segment by Type
1.2.1 Global Acinetobacter Infections Treatment Sales by Type (2016 & 2021 & 2027)
1.2.2 Sulbactam
1.2.3 Carbapenems
1.2.4 Aminoglycosides
1.2.5 Polymyxins
1.2.6 Tetracyclines
1.2.7 Others
1.3 Acinetobacter Infections Treatment Segment by Application
1.3.1 Global Acinetobacter Infections Treatment Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 ETX2514
1.3.3 Nacubactam RG6080
1.3.4 Arenicin
1.3.5 VXD-001
1.3.6 Small Molecule Antibiotic
1.3.7 AR-401 mAB
1.3.8 LCB01-0371 (PO)
1.3.9 GN-4474
1.3.10 Antibacterial Antibody
1.4 Acinetobacter Infections Treatment Market Estimates and Forecasts (2016-2027)
1.4.1 Global Acinetobacter Infections Treatment Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Acinetobacter Infections Treatment Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Acinetobacter Infections Treatment Price Trends (2016-2027)
2 Acinetobacter Infections Treatment Estimates and Forecasts by Region
2.1 Global Acinetobacter Infections Treatment Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Acinetobacter Infections Treatment Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Acinetobacter Infections Treatment Sales Market Share by Region (2016-2021)
2.2.2 Global Acinetobacter Infections Treatment Revenue Market Share by Region (2016-2021)
2.3 Global Acinetobacter Infections Treatment Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Acinetobacter Infections Treatment Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Acinetobacter Infections Treatment Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Acinetobacter Infections Treatment Estimates and Projections (2016-2027)
2.4.2 Europe Acinetobacter Infections Treatment Estimates and Projections (2016-2027)
2.4.3 China Acinetobacter Infections Treatment Estimates and Projections (2016-2027)
2.4.4 Japan Acinetobacter Infections Treatment Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Acinetobacter Infections Treatment Estimates and Projections (2016-2027)
2.4.6 India Acinetobacter Infections Treatment Estimates and Projections (2016-2027)
3 Global Acinetobacter Infections Treatment Competition Landscape by Players
3.1 Global Top Acinetobacter Infections Treatment Players by Sales (2016-2021)
3.2 Global Top Acinetobacter Infections Treatment Players by Revenue (2016-2021)
3.3 Global Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acinetobacter Infections Treatment as of 2020)
3.4 Global Acinetobacter Infections Treatment Average Price by Company (2016-2021)
3.5 Manufacturers Acinetobacter Infections Treatment Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Acinetobacter Infections Treatment Market Size by Type
4.1 Global Acinetobacter Infections Treatment Historic Market Review by Type (2016-2021)
4.1.1 Global Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)
4.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Type (2016-2021)
4.1.3 Global Acinetobacter Infections Treatment Price by Type (2016-2021)
4.2 Global Acinetobacter Infections Treatment Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Acinetobacter Infections Treatment Sales Forecast by Type (2022-2027)
4.2.2 Global Acinetobacter Infections Treatment Revenue Forecast by Type (2022-2027)
4.2.3 Global Acinetobacter Infections Treatment Price Forecast by Type (2022-2027)
5 Global Acinetobacter Infections Treatment Market Size by Application
5.1 Global Acinetobacter Infections Treatment Historic Market Review by Application (2016-2021)
5.1.1 Global Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)
5.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Application (2016-2021)
5.1.3 Global Acinetobacter Infections Treatment Price by Application (2016-2021)
5.2 Global Acinetobacter Infections Treatment Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Acinetobacter Infections Treatment Sales Forecast by Application (2022-2027)
5.2.2 Global Acinetobacter Infections Treatment Revenue Forecast by Application (2022-2027)
5.2.3 Global Acinetobacter Infections Treatment Price Forecast by Application (2022-2027)
6 North America Acinetobacter Infections Treatment Market Facts & Figures
6.1 North America Acinetobacter Infections Treatment Sales by Company
6.1.1 North America Acinetobacter Infections Treatment Sales by Company (2016-2021)
6.1.2 North America Acinetobacter Infections Treatment Revenue by Company (2016-2021)
6.2 North America Acinetobacter Infections Treatment Sales Breakdown by Type
6.2.1 North America Acinetobacter Infections Treatment Sales Breakdown by Type (2016-2021)
6.2.2 North America Acinetobacter Infections Treatment Sales Breakdown by Type (2022-2027)
6.3 North America Acinetobacter Infections Treatment Sales Breakdown by Application
6.3.1 North America Acinetobacter Infections Treatment Sales Breakdown by Application (2016-2021)
6.3.2 North America Acinetobacter Infections Treatment Sales Breakdown by Application (2022-2027)
7 Europe Acinetobacter Infections Treatment Market Facts & Figures
7.1 Europe Acinetobacter Infections Treatment Sales by Company
7.1.1 Europe Acinetobacter Infections Treatment Sales by Company (2016-2021)
7.1.2 Europe Acinetobacter Infections Treatment Revenue by Company (2016-2021)
7.2 Europe Acinetobacter Infections Treatment Sales Breakdown by Type
7.2.1 Europe Acinetobacter Infections Treatment Sales Breakdown by Type (2016-2021)
7.2.2 Europe Acinetobacter Infections Treatment Sales Breakdown by Type (2022-2027)
7.3 Europe Acinetobacter Infections Treatment Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)
8 China Acinetobacter Infections Treatment Market Facts & Figures
8.1 China Acinetobacter Infections Treatment Sales by Company
8.1.1 China Acinetobacter Infections Treatment Sales by Company (2016-2021)
8.1.2 China Acinetobacter Infections Treatment Revenue by Company (2016-2021)
8.2 China Acinetobacter Infections Treatment Sales Breakdown by Type
8.2.1 China Acinetobacter Infections Treatment Sales Breakdown by Type (2016-2021)
8.2.2 China Acinetobacter Infections Treatment Sales Breakdown by Type (2022-2027)
8.3 China Acinetobacter Infections Treatment Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Acinetobacter Infections Treatment Market Facts & Figures
9.1 Japan Acinetobacter Infections Treatment Sales by Company
9.1.1 Japan Acinetobacter Infections Treatment Sales by Company (2016-2021)
9.1.2 Japan Acinetobacter Infections Treatment Revenue by Company (2016-2021)
9.2 Japan Acinetobacter Infections Treatment Sales Breakdown by Type
9.2.1 Japan Acinetobacter Infections Treatment Sales Breakdown by Type (2016-2021)
9.2.2 Japan Acinetobacter Infections Treatment Sales Breakdown by Type (2022-2027)
9.3 Japan Acinetobacter Infections Treatment Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Acinetobacter Infections Treatment Market Facts & Figures
10.1 Southeast Asia Acinetobacter Infections Treatment Sales by Company
10.1.1 Southeast Asia Acinetobacter Infections Treatment Sales by Company (2016-2021)
10.1.2 Southeast Asia Acinetobacter Infections Treatment Revenue by Company (2016-2021)
10.2 Southeast Asia Acinetobacter Infections Treatment Sales Breakdown by Type
10.2.1 Southeast Asia Acinetobacter Infections Treatment Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Acinetobacter Infections Treatment Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Acinetobacter Infections Treatment Sales Breakdown by Application
10.3.1 Southeast Asia Cases Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Cases Sales Breakdown by Application (2022-2027)
11 India Acinetobacter Infections Treatment Market Facts & Figures
11.1 India Acinetobacter Infections Treatment Sales by Company
11.1.1 India Acinetobacter Infections Treatment Sales by Company (2016-2021)
11.1.2 India Acinetobacter Infections Treatment Revenue by Company (2016-2021)
11.2 India Acinetobacter Infections Treatment Sales Breakdown by Type
11.2.1 India Acinetobacter Infections Treatment Sales Breakdown by Type (2016-2021)
11.2.2 India Acinetobacter Infections Treatment Sales Breakdown by Type (2022-2027)
11.3 India Acinetobacter Infections Treatment Sales Breakdown by Application
11.3.1 India Acinetobacter Infections Treatment Sales Breakdown by Application (2016-2021)
11.3.2 India Acinetobacter Infections Treatment Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Acinetobacter Infections Treatment Business
12.1 Entasis Therapeutics
12.1.1 Entasis Therapeutics Corporation Information
12.1.2 Entasis Therapeutics Business Overview
12.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Products Offered
12.1.5 Entasis Therapeutics Recent Development
12.2 Roche
12.2.1 Roche Corporation Information
12.2.2 Roche Business Overview
12.2.3 Roche Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Roche Acinetobacter Infections Treatment Products Offered
12.2.5 Roche Recent Development
12.3 Adenium Biotech
12.3.1 Adenium Biotech Corporation Information
12.3.2 Adenium Biotech Business Overview
12.3.3 Adenium Biotech Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Adenium Biotech Acinetobacter Infections Treatment Products Offered
12.3.5 Adenium Biotech Recent Development
12.4 Vaxdyn
12.4.1 Vaxdyn Corporation Information
12.4.2 Vaxdyn Business Overview
12.4.3 Vaxdyn Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Vaxdyn Acinetobacter Infections Treatment Products Offered
12.4.5 Vaxdyn Recent Development
12.5 Hsiri Therapeutics
12.5.1 Hsiri Therapeutics Corporation Information
12.5.2 Hsiri Therapeutics Business Overview
12.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hsiri Therapeutics Acinetobacter Infections Treatment Products Offered
12.5.5 Hsiri Therapeutics Recent Development
12.6 Aridis Pharmaceuticals
12.6.1 Aridis Pharmaceuticals Corporation Information
12.6.2 Aridis Pharmaceuticals Business Overview
12.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Products Offered
12.6.5 Aridis Pharmaceuticals Recent Development
12.7 LegoChem Biosciences
12.7.1 LegoChem Biosciences Corporation Information
12.7.2 LegoChem Biosciences Business Overview
12.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.7.4 LegoChem Biosciences Acinetobacter Infections Treatment Products Offered
12.7.5 LegoChem Biosciences Recent Development
12.8 Atterx Biotherapeutics
12.8.1 Atterx Biotherapeutics Corporation Information
12.8.2 Atterx Biotherapeutics Business Overview
12.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Atterx Biotherapeutics Acinetobacter Infections Treatment Products Offered
12.8.5 Atterx Biotherapeutics Recent Development
12.9 Achaogen
12.9.1 Achaogen Corporation Information
12.9.2 Achaogen Business Overview
12.9.3 Achaogen Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Achaogen Acinetobacter Infections Treatment Products Offered
12.9.5 Achaogen Recent Development
12.10 Peptilogics
12.10.1 Peptilogics Corporation Information
12.10.2 Peptilogics Business Overview
12.10.3 Peptilogics Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Peptilogics Acinetobacter Infections Treatment Products Offered
12.10.5 Peptilogics Recent Development
12.11 Sealife PHARMA
12.11.1 Sealife PHARMA Corporation Information
12.11.2 Sealife PHARMA Business Overview
12.11.3 Sealife PHARMA Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sealife PHARMA Acinetobacter Infections Treatment Products Offered
12.11.5 Sealife PHARMA Recent Development
12.12 Shionogi
12.12.1 Shionogi Corporation Information
12.12.2 Shionogi Business Overview
12.12.3 Shionogi Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Shionogi Acinetobacter Infections Treatment Products Offered
12.12.5 Shionogi Recent Development
12.13 Techulon
12.13.1 Techulon Corporation Information
12.13.2 Techulon Business Overview
12.13.3 Techulon Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Techulon Acinetobacter Infections Treatment Products Offered
12.13.5 Techulon Recent Development
12.14 Tetraphase Pharmaceuticals
12.14.1 Tetraphase Pharmaceuticals Corporation Information
12.14.2 Tetraphase Pharmaceuticals Business Overview
12.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Products Offered
12.14.5 Tetraphase Pharmaceuticals Recent Development
13 Acinetobacter Infections Treatment Manufacturing Cost Analysis
13.1 Acinetobacter Infections Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Acinetobacter Infections Treatment
13.4 Acinetobacter Infections Treatment Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Acinetobacter Infections Treatment Distributors List
14.3 Acinetobacter Infections Treatment Customers
15 Market Dynamics
15.1 Acinetobacter Infections Treatment Market Trends
15.2 Acinetobacter Infections Treatment Drivers
15.3 Acinetobacter Infections Treatment Market Challenges
15.4 Acinetobacter Infections Treatment Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Acinetobacter Infections Treatment Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Acinetobacter Infections Treatment Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Acinetobacter Infections Treatment Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Acinetobacter Infections Treatment Sales (Cases) by Region (2016-2021)
Table 5. Global Acinetobacter Infections Treatment Sales Market Share by Region (2016-2021)
Table 6. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Acinetobacter Infections Treatment Revenue Share by Region (2016-2021)
Table 8. Global Acinetobacter Infections Treatment Sales (Cases) Forecast by Region (2022-2027)
Table 9. Global Acinetobacter Infections Treatment Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Acinetobacter Infections Treatment Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Acinetobacter Infections Treatment Revenue Share Forecast by Region (2022-2027)
Table 12. Global Acinetobacter Infections Treatment Sales (Cases) of Key Companies (2016-2021)
Table 13. Global Acinetobacter Infections Treatment Sales Share by Company (2016-2021)
Table 14. Global Acinetobacter Infections Treatment Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Acinetobacter Infections Treatment Revenue Share by Company (2016-2021)
Table 16. Global Acinetobacter Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acinetobacter Infections Treatment as of 2020)
Table 17. Global Acinetobacter Infections Treatment Average Price (USD/Case) of Key Company (2016-2021)
Table 18. Manufacturers Acinetobacter Infections Treatment Manufacturing Sites and Area Served
Table 19. Manufacturers Acinetobacter Infections Treatment Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Acinetobacter Infections Treatment Sales (Cases) by Type (2016-2021)
Table 22. Global Acinetobacter Infections Treatment Sales Share by Type (2016-2021)
Table 23. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Acinetobacter Infections Treatment Price (USD/Case) by Type (2016-2021)
Table 25. Global Acinetobacter Infections Treatment Sales Share by Type (2022-2027)
Table 26. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Acinetobacter Infections Treatment Revenue Share by Type (2022-2027)
Table 28. Global Acinetobacter Infections Treatment Price (USD/Case) by Type (2022-2027)
Table 29. Global Acinetobacter Infections Treatment Sales (Cases) by Application (2016-2021)
Table 30. Global Acinetobacter Infections Treatment Sales Share by Application (2016-2021)
Table 31. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Acinetobacter Infections Treatment Price (USD/Case) by Application (2016-2021)
Table 33. Global Acinetobacter Infections Treatment Sales (Cases) by Application (2022-2027)
Table 34. Global Acinetobacter Infections Treatment Sales Share by Application (2022-2027)
Table 35. Global Acinetobacter Infections Treatment Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Acinetobacter Infections Treatment Revenue Share by Application (2022-2027)
Table 37. Global Acinetobacter Infections Treatment Price (USD/Case) by Application (2022-2027)
Table 38. North America Acinetobacter Infections Treatment Sales (Cases) by Company (2016-2021)
Table 39. North America Acinetobacter Infections Treatment Sales Market Share by Company (2016-2021)
Table 40. North America Acinetobacter Infections Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Acinetobacter Infections Treatment Revenue Market Share by Company (2016-2021)
Table 42. North America Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)
Table 43. North America Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)
Table 44. North America Acinetobacter Infections Treatment Sales by Type (2022-2027) & (Cases)
Table 45. North America Acinetobacter Infections Treatment Sales Market Share by Type (2022-2027)
Table 46. North America Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)
Table 47. North America Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)
Table 48. North America Acinetobacter Infections Treatment Sales by Application (2022-2027) & (Cases)
Table 49. North America Acinetobacter Infections Treatment Sales Market Share by Application (2022-2027)
Table 50. Europe Acinetobacter Infections Treatment Sales (Cases) by Company (2016-2021)
Table 51. Europe Acinetobacter Infections Treatment Sales Market Share by Company (2016-2021)
Table 52. Europe Acinetobacter Infections Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Acinetobacter Infections Treatment Revenue Market Share by Company (2016-2021)
Table 54. Europe Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)
Table 55. Europe Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)
Table 56. Europe Acinetobacter Infections Treatment Sales by Type (2022-2027) & (Cases)
Table 57. Europe Acinetobacter Infections Treatment Sales Market Share by Type (2022-2027)
Table 58. Europe Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)
Table 59. Europe Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)
Table 60. Europe Acinetobacter Infections Treatment Sales by Application (2022-2027) & (Cases)
Table 61. Europe Acinetobacter Infections Treatment Sales Market Share by Application (2022-2027)
Table 62. China Acinetobacter Infections Treatment Sales (Cases) by Company (2016-2021)
Table 63. China Acinetobacter Infections Treatment Sales Market Share by Company (2016-2021)
Table 64. China Acinetobacter Infections Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Acinetobacter Infections Treatment Revenue Market Share by Company (2016-2021)
Table 66. China Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)
Table 67. China Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)
Table 68. China Acinetobacter Infections Treatment Sales by Type (2022-2027) & (Cases)
Table 69. China Acinetobacter Infections Treatment Sales Market Share by Type (2022-2027)
Table 70. China Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)
Table 71. China Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)
Table 72. China Acinetobacter Infections Treatment Sales by Application (2022-2027) & (Cases)
Table 73. China Acinetobacter Infections Treatment Sales Market Share by Application (2022-2027)
Table 74. Japan Acinetobacter Infections Treatment Sales (Cases) by Company (2016-2021)
Table 75. Japan Acinetobacter Infections Treatment Sales Market Share by Company (2016-2021)
Table 76. Japan Acinetobacter Infections Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Acinetobacter Infections Treatment Revenue Market Share by Company (2016-2021)
Table 78. Japan Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)
Table 79. Japan Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)
Table 80. Japan Acinetobacter Infections Treatment Sales by Type (2022-2027) & (Cases)
Table 81. Japan Acinetobacter Infections Treatment Sales Market Share by Type (2022-2027)
Table 82. Japan Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)
Table 83. Japan Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)
Table 84. Japan Acinetobacter Infections Treatment Sales by Application (2022-2027) & (Cases)
Table 85. Japan Acinetobacter Infections Treatment Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Acinetobacter Infections Treatment Sales (Cases) by Company (2016-2021)
Table 87. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Acinetobacter Infections Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Acinetobacter Infections Treatment Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)
Table 91. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Acinetobacter Infections Treatment Sales by Type (2022-2027) & (Cases)
Table 93. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)
Table 95. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Acinetobacter Infections Treatment Sales by Application (2022-2027) & (Cases)
Table 97. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Application (2022-2027)
Table 98. India Acinetobacter Infections Treatment Sales (Cases) by Company (2016-2021)
Table 99. India Acinetobacter Infections Treatment Sales Market Share by Company (2016-2021)
Table 100. India Acinetobacter Infections Treatment Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Acinetobacter Infections Treatment Revenue Market Share by Company (2016-2021)
Table 102. India Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)
Table 103. India Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)
Table 104. India Acinetobacter Infections Treatment Sales by Type (2022-2027) & (Cases)
Table 105. India Acinetobacter Infections Treatment Sales Market Share by Type (2022-2027)
Table 106. India Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)
Table 107. India Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)
Table 108. India Acinetobacter Infections Treatment Sales by Application (2022-2027) & (Cases)
Table 109. India Acinetobacter Infections Treatment Sales Market Share by Application (2022-2027)
Table 110. Entasis Therapeutics Corporation Information
Table 111. Entasis Therapeutics Description and Business Overview
Table 112. Entasis Therapeutics Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 113. Entasis Therapeutics Acinetobacter Infections Treatment Product
Table 114. Entasis Therapeutics Recent Development
Table 115. Roche Corporation Information
Table 116. Roche Description and Business Overview
Table 117. Roche Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 118. Roche Acinetobacter Infections Treatment Product
Table 119. Roche Recent Development
Table 120. Adenium Biotech Corporation Information
Table 121. Adenium Biotech Description and Business Overview
Table 122. Adenium Biotech Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 123. Adenium Biotech Acinetobacter Infections Treatment Product
Table 124. Adenium Biotech Recent Development
Table 125. Vaxdyn Corporation Information
Table 126. Vaxdyn Description and Business Overview
Table 127. Vaxdyn Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 128. Vaxdyn Acinetobacter Infections Treatment Product
Table 129. Vaxdyn Recent Development
Table 130. Hsiri Therapeutics Corporation Information
Table 131. Hsiri Therapeutics Description and Business Overview
Table 132. Hsiri Therapeutics Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 133. Hsiri Therapeutics Acinetobacter Infections Treatment Product
Table 134. Hsiri Therapeutics Recent Development
Table 135. Aridis Pharmaceuticals Corporation Information
Table 136. Aridis Pharmaceuticals Description and Business Overview
Table 137. Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 138. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product
Table 139. Aridis Pharmaceuticals Recent Development
Table 140. LegoChem Biosciences Corporation Information
Table 141. LegoChem Biosciences Description and Business Overview
Table 142. LegoChem Biosciences Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 143. LegoChem Biosciences Acinetobacter Infections Treatment Product
Table 144. LegoChem Biosciences Recent Development
Table 145. Atterx Biotherapeutics Corporation Information
Table 146. Atterx Biotherapeutics Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 147. Atterx Biotherapeutics Description and Business Overview
Table 148. Atterx Biotherapeutics Acinetobacter Infections Treatment Product
Table 149. Atterx Biotherapeutics Recent Development
Table 150. Achaogen Corporation Information
Table 151. Achaogen Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 152. Achaogen Description and Business Overview
Table 153. Achaogen Acinetobacter Infections Treatment Product
Table 154. Achaogen Recent Development
Table 155. Peptilogics Corporation Information
Table 156. Peptilogics Description and Business Overview
Table 157. Peptilogics Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 158. Peptilogics Acinetobacter Infections Treatment Product
Table 159. Peptilogics Recent Development
Table 160. Sealife PHARMA Corporation Information
Table 161. Sealife PHARMA Description and Business Overview
Table 162. Sealife PHARMA Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 163. Sealife PHARMA Acinetobacter Infections Treatment Product
Table 164. Sealife PHARMA Recent Development
Table 165. Shionogi Corporation Information
Table 166. Shionogi Description and Business Overview
Table 167. Shionogi Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 168. Shionogi Acinetobacter Infections Treatment Product
Table 169. Shionogi Recent Development
Table 170. Techulon Corporation Information
Table 171. Techulon Description and Business Overview
Table 172. Techulon Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 173. Techulon Acinetobacter Infections Treatment Product
Table 174. Techulon Recent Development
Table 175. Tetraphase Pharmaceuticals Corporation Information
Table 176. Tetraphase Pharmaceuticals Description and Business Overview
Table 177. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales (Cases), Revenue (Million USD), Price (USD/Case) and Gross Margin (2016-2021)
Table 178. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product
Table 179. Tetraphase Pharmaceuticals Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Acinetobacter Infections Treatment Distributors List
Table 183. Acinetobacter Infections Treatment Customers List
Table 184. Acinetobacter Infections Treatment Market Trends
Table 185. Acinetobacter Infections Treatment Market Drivers
Table 186. Acinetobacter Infections Treatment Market Challenges
Table 187. Acinetobacter Infections Treatment Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Acinetobacter Infections Treatment Product Picture
Figure 2. Global Acinetobacter Infections Treatment Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Acinetobacter Infections Treatment Sales Market Share by Application in 2021 & 2027
Figure 6. ETX2514 Examples
Figure 7. Nacubactam RG6080 Examples
Figure 8. Arenicin Examples
Figure 9. VXD-001 Examples
Figure 10. Small Molecule Antibiotic Examples
Figure 11. AR-401 mAB Examples
Figure 12. LCB01-0371 (PO) Examples
Figure 13. GN-4474 Examples
Figure 14. Antibacterial Antibody Examples
Figure 15. Global Acinetobacter Infections Treatment Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Acinetobacter Infections Treatment Sales Growth Rate (2016-2027) & (US$ Million)
Figure 17. Global Acinetobacter Infections Treatment Sales (Cases) Growth Rate (2016-2027)
Figure 18. Global Acinetobacter Infections Treatment Price Trends Growth Rate (2016-2027) (USD/Case)
Figure 19. Global Acinetobacter Infections Treatment Revenue Market Share by Region: 2016 VS 2021
Figure 20. Global Acinetobacter Infections Treatment Revenue Market Share by Region: 2021 VS 2027
Figure 21. North America Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. North America Acinetobacter Infections Treatment Sales (Cases) Growth Rate (2016-2027)
Figure 23. Europe Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Europe Acinetobacter Infections Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 25. China Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. China Acinetobacter Infections Treatment Sales (Million USD) and Growth Rate (2016-2027)
Figure 27. Japan Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Japan Acinetobacter Infections Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. Southeast Asia Acinetobacter Infections Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 31. India Acinetobacter Infections Treatment Revenue (Million USD) Growth Rate (2016-2027)
Figure 32. India Acinetobacter Infections Treatment Sales (Million USD) Growth Rate (2016-2027)
Figure 33. Global 5 Largest Acinetobacter Infections Treatment Players Market Share by Revenue in Acinetobacter Infections Treatment: 2016 & 2020
Figure 34. Acinetobacter Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 35. Global Acinetobacter Infections Treatment Revenue Share by Type (2016-2021)
Figure 36. Global Acinetobacter Infections Treatment Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Global Acinetobacter Infections Treatment Revenue Share by Application (2016-2021)
Figure 38. Global Acinetobacter Infections Treatment Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Acinetobacter Infections Treatment Sales Market Share by Type in 2020
Figure 40. North America Acinetobacter Infections Treatment Sales Market Share by Application in 2020
Figure 41. Europe Acinetobacter Infections Treatment Sales Market Share by Type in 2020
Figure 42. Europe Acinetobacter Infections Treatment Sales Market Share by Application in 2020
Figure 43. China Acinetobacter Infections Treatment Sales Market Share by Type in 2020
Figure 44. China Acinetobacter Infections Treatment Sales Market Share by Application in 2020
Figure 45. Japan Acinetobacter Infections Treatment Sales Market Share by Type in 2020
Figure 46. Japan Acinetobacter Infections Treatment Sales Market Share by Application in 2020
Figure 47. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Type in 2020
Figure 48. Southeast Asia Acinetobacter Infections Treatment Sales Market Share by Application in 2020
Figure 49. India Acinetobacter Infections Treatment Sales Market Share by Type in 2020
Figure 50. India Acinetobacter Infections Treatment Sales Market Share by Application in 2020
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Acinetobacter Infections Treatment
Figure 53. Manufacturing Process Analysis of Acinetobacter Infections Treatment
Figure 54. Acinetobacter Infections Treatment Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed